Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Directorate change

Today 07:00

RNS Number : 2721J
Herald Investment Trust PLC
23 June 2026
 

LEI: 213800U7G1ROCTJYRR70

 

Herald Investment Trust plc

(the "Company")

 

Directorate Changes

 

 

The Company is pleased to announce the appointment of Joanne Parfrey as an independent non-executive director and Audit Committee Chair designate of the Company with effect from 1 July 2026. Ms Parfrey will succeed Stephanie Eastment as Audit Committee Chair on 1 October 2026. Ms Eastment will remain on the Board as a non-executive Director to provide continuity to the Board together with a managed handover of audit responsibilities.

 

Ms Parfrey is currently a non-executive director of Worldwide Healthcare Trust plc and the non-executive chair of Octopus AIM VCT plc.

 

She is an experienced investor with a background in private equity with LGV Capital Partners Limited, where she was on the board. Joanne has experience of global investment trusts having formerly been a non-executive director and chair of the audit committee of Henderson International Income Trust plc. Ms Parfrey studied chemistry at Oxford University and is a Chartered Accountant by training.

 

As at the date of this announcement Ms Parfrey was beneficially interested in 1,000 shares of the Company.

 

No further information in respect of Ms Parfrey is required to be disclosed pursuant to UK Listing Rule 6.4.8R (1) to (6).

 

The Board also notes that Henrietta Marsh will not be standing for re-election at the Company's forthcoming AGM on 30 June 2026. The Board would like to thank Ms Marsh very much for her valuable contribution to the Company. Christopher Metcalfe will succeed Ms Marsh as Senior Independent Director from the conclusion of the AGM.

 

Enquiries

 

NSM Funds (UK) Limited

Company Secretary

Email: HIT@nsm.group

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAPPUBAQUPQPGP

Related Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Back to RNS